SEC Form D filing

Stipple Bio, Inc., 2026-04-06

An SEC Form D private-offering notice from Cambridge, MA, a $100,200,007 filer-stated offering target in Biotech. Filed 2026-04-06. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Stipple Bio, Inc. site↗ Verified via SEC Form D

Precision oncology biotech using its Pointillist epitope discovery platform to identify tumor specific cell surface targets for antibody drug conjugates; recently closed a $100 million Series A.

Filed 2026-04-06Filed to raise $100,200,007First money in 2026-03-31Raised so far $65,130,013HQ (as filed) Cambridge, MASector Biotech web-verified against the company’s own siteStage (inferred) LateCall status Call-ready
Source linked the Form D on EDGAR↗Website verified stipple.bio↗Named in the filing 7 executives & directors
Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source